L. Buonocore

发表

Liposome‐Mediated Transfection

M. Whitt, J. Rose, L. Buonocore, 1991, Current protocols in molecular biology.

CD4IsRetained intheEndoplasmic Reticulum bytheHuman Immunodeficiency VirusType1Glycoprotein Precursor

B. Crise, L. Buonocore, 1990 .

In vitro evolution of high-titer, virus-like vesicles containing a single structural protein

Xinran Liu, J. Rose, L. Buonocore, 2014, Proceedings of the National Academy of Sciences.

Naturally occurring methylation inhibitor: DNA hypomethylation and hemoglobin synthesis in human K562 cells

M. Miller, L. Buonocore, S. Lyon, 1987 .

Development of a Novel Surrogate Virus for Human T-Cell Leukemia Virus Type 1: Inhibition of Infection by Osteoprotegerin

E. Ramsburg, J. Rose, L. Buonocore, 2003, Journal of Virology.

Viral vectored granulocyte-macrophage colony stimulating factor inhibits vaccine protection in an SIV challenge model: protection correlates with neutralizing antibody.

D. Montefiori, P. Marx, C. Labranche, 2012, Vaccine.

A Vesicular Stomatitis Virus-Based Hepatitis B Virus Vaccine Vector Provides Protection against Challenge in a Single Dose

M. Cobleigh, J. Rose, L. Buonocore, 2010, Journal of Virology.

Vesicular Stomatitis Virus-Based Therapeutic Vaccination Targeted to the E1, E2, E6, and E7 Proteins of Cottontail Rabbit Papillomavirus

D. Zelterman, A. Roberts, J. Rose, 2007, Journal of Virology.

Therapeutic efficacy of vesicular stomatitis virus-based E6 vaccination in rabbits.

A. Roberts, J. Rose, L. Buonocore, 2007, Vaccine.

Characterization of Vesicular Stomatitis Virus Recombinants That Express and Incorporate High Levels of Hepatitis C Virus Glycoproteins

C. Rice, K. Blight, J. Rose, 2002, Journal of Virology.

Attenuated Vesicular Stomatitis Viruses as Vaccine Vectors

A. Roberts, J. Rose, L. Buonocore, 1999, Journal of Virology.

A Viable Recombinant Rhabdovirus Lacking Its Glycoprotein Gene and Expressing Influenza Virus Hemagglutinin and Neuraminidase Is a Potent Influenza Vaccine

F. Krammer, J. Rose, L. Buonocore, 2014, Journal of Virology.

Replication-Competent or Attenuated, Nonpropagating Vesicular Stomatitis Viruses Expressing Respiratory Syncytial Virus (RSV) Antigens Protect Mice against RSV Challenge

A. Roberts, J. Kahn, J. Rose, 2001, Journal of Virology.

Mechanisms of loss of foreign gene expression in recombinant vesicular stomatitis viruses.

J. Rose, L. Buonocore, M. Schnell, 2001, Virology.

Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles.

J. Rose, E. Kretzschmar, L. Buonocore, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Development of an infectious surrogate hepatitis C virus based on a recombinant vesicular stomatitis virus expressing hepatitis C virus envelope glycoproteins and green fluorescent protein.

J. Rose, L. Buonocore, M. Hiyoshi, 2015, Japanese journal of infectious diseases.

Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection

J. Rose, L. Buonocore, Nina F. Rose, 2015, Journal of Virology.

Potent Vesicular Stomatitis Virus-Based Avian Influenza Vaccines Provide Long-Term Sterilizing Immunity against Heterologous Challenge

G. Kobinger, H. Feldmann, K. Subbarao, 2010, Journal of Virology.

A Vesicular Stomatitis Virus Recombinant Expressing Granulocyte-Macrophage Colony-Stimulating Factor Induces Enhanced T-Cell Responses and Is Highly Attenuated for Replication in Animals

E. Ramsburg, J. Rose, L. Buonocore, 2005, Journal of Virology.

Naturally occurring methylation inhibitor: DNA hypomethylation and hemoglobin synthesis in human K562 cells

L. Buonocore, M. Miller, S. Lyon, 1987, Molecular and cellular biology.

Vesicular Stomatitis Virus-Based H5N1 Avian Influenza Vaccines Induce Potent Cross-Clade Neutralizing Antibodies in Rhesus Macaques

K. Subbarao, P. Marx, J. Rose, 2011, Journal of Virology.

Vesicular Stomatitis Virus-Based H5N1 Avian Inﬂuenza Vaccines Induce Potent Cross-Clade Neutralizing Antibodies in Rhesus Macaques (cid:1)

K. Subbarao, P. Marx, L. Buonocore, 2011 .

Requirement for a non‐specific glycoprotein cytoplasmic domain sequence to drive efficient budding of vesicular stomatitis virus

E. Boritz, R. Chernish, J. Rose, 1998, The EMBO journal.

Recycling of receptor-bound IgE by rat basophilic leukemia cells.

J. Rivera, K. Furuichi, L. Buonocore, 1986, Journal of immunology.

Intranasal immunization with recombinant vesicular stomatitis virus expressing murine cytomegalovirus glycoprotein B induces humoral and cellular immunity.

J. Rose, L. Buonocore, Jean Wilson, 2008, Comparative medicine.

Membrane fusion activity, oligomerization, and assembly of the rabies virus glycoprotein.

M. Whitt, J. Rose, L. Buonocore, 1991, Virology.

Liposome‐Mediated Transfection

M. Whitt, J. Rose, L. Buonocore, 1992, Current protocols in immunology.

Recombinant vesicular stomatitis virus expressing respiratory syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate infection and cell fusion.

J. Kahn, J. Rose, L. Buonocore, 1999, Virology.

Construction of a Novel Virus That Targets HIV-1-Infected Cells and Controls HIV-1 Infection

J. Rose, L. Buonocore, M. Schnell, 1997, Cell.

Role of N-Linked Glycans in a Human Immunodeficiency Virus Envelope Glycoprotein: Effects on Protein Function and the Neutralizing Antibody Response

J. Rose, L. Buonocore, M. I. Quiñones-Kochs, 2002, Journal of Virology.

Successful Vaccine-Induced Seroconversion by Single-Dose Immunization in the Presence of Measles Virus-Specific Maternal Antibodies

V. ter meulen, J. Rose, L. Buonocore, 2000, Journal of Virology.

Specific targeting to CD4+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins

J. Johnson, J. Rose, L. Buonocore, 1997, Journal of virology.

Prevention of HIV-1 glycoprotein transport by soluble CD4 retained in the endoplasmic reticulum

J. Rose, L. Buonocore, 1990, Nature.

CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor

B. Crise, J. Rose, L. Buonocore, 1990, Journal of virology.

Structure of the Low pH Conformation of Chandipura Virus G Reveals Important Features in the Evolution of the Vesiculovirus Glycoprotein

Y. Gaudin, S. Bressanelli, J. Rose, 2015, PLoS pathogens.

Successful mucosal immunization of cotton rats in the presence of measles virus-specific antibodies depends on degree of attenuation of vaccine vector and virus dose.

J. Rose, L. Buonocore, B. Schlereth, 2003, The Journal of general virology.

An Effective AIDS Vaccine Based on Live Attenuated Vesicular Stomatitis Virus Recombinants

David Montefiori, John K. Rose, Douglas F. Nixon, 2001, Cell.

Glycoprotein Exchange Vectors Based on Vesicular Stomatitis Virus Allow Effective Boosting and Generation of Neutralizing Antibodies to a Primary Isolate of Human Immunodeficiency Virus Type 1

A. Roberts, J. Rose, L. Buonocore, 2000, Journal of Virology.

Structural intermediates in the fusion‐associated transition of vesiculovirus glycoprotein

J. Lepault, Y. Gaudin, S. Bressanelli, 2016, The EMBO journal.

Vaccination with a Recombinant Vesicular Stomatitis Virus Expressing an Influenza Virus Hemagglutinin Provides Complete Protection from Influenza Virus Challenge

Y. Kawaoka, A. Roberts, A. Perkins, 1998, Journal of Virology.

Vesicular stomatitis virus vectors expressing avian influenza H5 HA induce cross-neutralizing antibodies and long-term protection.

G. Kobinger, H. Feldmann, K. Subbarao, 2007, Virology.

The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus

M. Whitt, J. Rose, L. Buonocore, 1996, Journal of virology.

A recombinant vesicular stomatitis virus encoding CCR5-tropic HIV-1 receptors targets HIV-1-infected cells and controls HIV-1 infection.

Mamoru Ito, Yuetsu Tanaka, J. Rose, 2017, Microbes and infection.

High-Level Primary CD8+ T-Cell Response to Human Immunodeficiency Virus Type 1 Gag and Env Generated by Vaccination with Recombinant Vesicular Stomatitis Viruses

E. Pamer, J. Rose, L. Buonocore, 2002, Journal of Virology.

Reversal of papilloma growth in rabbits therapeutically vaccinated against E6 with naked DNA and/or vesicular stomatitis virus vectors.

D. Zelterman, J. Rose, L. Buonocore, 2010, Vaccine.

High-efficiency incorporation of functional influenza virus glycoproteins into recombinant vesicular stomatitis viruses

J. Rose, E. Kretzschmar, L. Buonocore, 1997, Journal of virology.

Robust Recall and Long-Term Memory T-Cell Responses Induced by Prime-Boost Regimens with Heterologous Live Viral Vectors Expressing Human Immunodeficiency Virus Type 1 Gag and Env Proteins

E. Pamer, J. Rose, L. Buonocore, 2002, Journal of Virology.

A new cationic liposome reagent mediating nearly quantitative transfection of animal cells.

M. Whitt, J. Rose, L. Buonocore, 1991, BioTechniques.

Significant Protection against High-Dose Simian Immunodeficiency Virus Challenge Conferred by a New Prime-Boost Vaccine Regimen

D. Montefiori, P. Marx, J. Rose, 2011, Journal of Virology.

Conservation of the respiratory syncytial virus SH gene.

J. Kahn, L. Buonocore, M. Vázquez, 2000, The Journal of infectious diseases.

Antigenic requirement for Gag in a vaccine that protects against high-dose mucosal challenge with simian immunodeficiency virus.

P. Marx, J. Rose, L. Buonocore, 2015, Virology.

Stimulation of heterologous protein degradation by the Vpu protein of HIV-1 requires the transmembrane and cytoplasmic domains of CD4.

B. Crise, J. Rose, L. Buonocore, 1994, Virology.

Presence of bovine viral diarrhea virus (BVDV) E2 glycoprotein in VSV recombinant particles and induction of neutralizing BVDV antibodies in mice.

J. Rose, L. Buonocore, R. Donis, 2000, Virus research.

Blockade of human immunodeficiency virus type 1 production in CD4+ T cells by an intracellular CD4 expressed under control of the viral long terminal repeat.

J. Rose, L. Buonocore, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains

P. Palese, F. Krammer, J. Rose, 2015, Journal of Virology.

Crystallization and preliminary X-ray analysis of Chandipura virus glycoprotein G.

Y. Gaudin, S. Bressanelli, J. Rose, 2012, Acta crystallographica. Section F, Structural biology and crystallization communications.

Immunodeficiency Virus Type 1 Antibodies to a Primary Isolate of Human Boosting and Generation of Neutralizing Vesicular Stomatitis Virus Allow Effective Glycoprotein Exchange Vectors Based on

A. Roberts, J. Rose, L. Buonocore, 2000 .

Antigenic requirement for Gag in a vaccine that protects against high-dose mucosal challenge with simian immunodeficiency virus.

P. Marx, J. Rose, L. Buonocore, 2015, Virology.

Reversal of papilloma growth in rabbits therapeutically vaccinated against E6 with naked DNA and/or vesicular stomatitis virus vectors.

D. Zelterman, J. Rose, L. Buonocore, 2010, Vaccine.